Home

opakovat Pověření turistika cd38 prognostic marker cll Sklad skříň poloměr

Prognostic markers and their clinical applicability in chronic lymphocytic  leukemia: where do we stand?
Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?

Frontiers | Importance of Crosstalk Between Chronic Lymphocytic Leukemia  Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors,  and Extracellular Vesicles
Frontiers | Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles

Prognostic Factors
Prognostic Factors

Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From  Tumor–Microenvironment Cell Interactions to Acquired Resistance to  Immunotherapy
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy

An international prognostic index for patients with chronic lymphocytic  leukaemia (CLL-IPI): a meta-analysis of individual patient data - The  Lancet Oncology
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data - The Lancet Oncology

Pathology Outlines - CD38
Pathology Outlines - CD38

Prognostic biomarkers in chronic lymphocytic leukemia | Download Scientific  Diagram
Prognostic biomarkers in chronic lymphocytic leukemia | Download Scientific Diagram

Regulation of CD38 in proliferating chronic lymphocytic leukemia cells  stimulated with CD154 and interleukin-4 | Haematologica
Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4 | Haematologica

Prognostic factors in chronic lymphocytic leukemia—what do we need to know?  | Nature Reviews Clinical Oncology
Prognostic factors in chronic lymphocytic leukemia—what do we need to know? | Nature Reviews Clinical Oncology

Frontiers | Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A  Contemporary Perspective
Frontiers | Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective

Driving Out Chronic Lymphocytic Leukemia With CAR T Cells - Transplantation  and Cellular Therapy, Official Publication of the American Society for  Transplantation and Cellular Therapy
Driving Out Chronic Lymphocytic Leukemia With CAR T Cells - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy

Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic  Leukemia | PLOS ONE
Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia | PLOS ONE

Cancers | Free Full-Text | An Updated Perspective on Current Prognostic and  Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of  Chemoimmunotherapy and Novel Targeted Therapy
Cancers | Free Full-Text | An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy

IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia ( CLL) - Insights
IGHV and TP53 Sequencing: Clinical Utility in Chronic Lymphocytic Leukemia ( CLL) - Insights

Relationship between IGHV mutation status and ZAP-70 or CD38 in... |  Download Scientific Diagram
Relationship between IGHV mutation status and ZAP-70 or CD38 in... | Download Scientific Diagram

The influence of the clinical prognostic markers age, gender, Rai... |  Download Scientific Diagram
The influence of the clinical prognostic markers age, gender, Rai... | Download Scientific Diagram

The pathogenic relevance of the prognostic markers CD38 and CD49d in  chronic lymphocytic leukemia | SpringerLink
The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia | SpringerLink

CD38+ chronic lymphocytic leukaemia cells co-express high levels of ZAP-70  and are functionally distinct from their CD38− counter-parts | Leukemia
CD38+ chronic lymphocytic leukaemia cells co-express high levels of ZAP-70 and are functionally distinct from their CD38− counter-parts | Leukemia

LPL is the strongest prognostic factor in a comparative analysis of  RNA-based markers in early chronic lymphocytic leukemia | Haematologica
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia | Haematologica

Evaluation of prognostic variables in chronic lymphocytic leukemia and  association with disease stage
Evaluation of prognostic variables in chronic lymphocytic leukemia and association with disease stage

CD38 as a prognostic marker in CLL: Hematology: Vol 10, No 1
CD38 as a prognostic marker in CLL: Hematology: Vol 10, No 1

Impact of cytogenetic and molecular prognostic markers on the clinical  management of chronic lymphocytic leukemia | Haematologica
Impact of cytogenetic and molecular prognostic markers on the clinical management of chronic lymphocytic leukemia | Haematologica

The diagnostic and prognostic value of CD38 and CD49d expressions in  chronic lymphocytic leukemia Hendy OM, El Shafie MA, Allam MM, Motalib TA,  Khalaf FA, Gohar SF - Egypt J Haematol
The diagnostic and prognostic value of CD38 and CD49d expressions in chronic lymphocytic leukemia Hendy OM, El Shafie MA, Allam MM, Motalib TA, Khalaf FA, Gohar SF - Egypt J Haematol

CD38 expression is an important prognostic marker in chronic lymphocytic  leukaemia | Leukemia
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia | Leukemia

Pathogenic steps and corresponding prognostic markers. | Download  Scientific Diagram
Pathogenic steps and corresponding prognostic markers. | Download Scientific Diagram

The diagnostic and prognostic value of CD38 and CD49d expressions in  chronic lymphocytic leukemia Hendy OM, El Shafie MA, Allam MM, Motalib TA,  Khalaf FA, Gohar SF - Egypt J Haematol
The diagnostic and prognostic value of CD38 and CD49d expressions in chronic lymphocytic leukemia Hendy OM, El Shafie MA, Allam MM, Motalib TA, Khalaf FA, Gohar SF - Egypt J Haematol